Preferences for Use and Design of Electronic Patient-Reported Outcomes in Patients with Chronic Obstructive Pulmonary Disease.


Journal

The patient
ISSN: 1178-1661
Titre abrégé: Patient
Pays: New Zealand
ID NLM: 101309314

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 18 7 2019
medline: 25 8 2020
entrez: 18 7 2019
Statut: ppublish

Résumé

Collection of patient-reported outcome (PRO) measures is critical to fully understand chronic obstructive pulmonary disease (COPD) management and progression, as the impact on health-related quality of life is not well understood by objective measures alone. Electronic PROs (ePROs) are increasingly used because of their advantages over paper data collection, including elimination of transcription errors, increased accuracy and data quality, real-time data reporting, and increased compliance. The objective of this study was to characterize how patients with COPD prefer to use various types of technology to report disease symptoms, and their preferences for ePRO design and display. The sample consisted of subjects with COPD (N = 103) who completed in-person surveys on their ePRO preferences. The majority of subjects prefer to use a form of electronic media over paper to report their disease symptoms. Of these electronic methods, subjects most often prefer to use a smartphone provided by their physician. Subjects were also interested in ePRO features, such as knowing estimated PRO completion time at the outset, tracking their progress in real time as they complete a questionnaire, seeing the data that they report in order to track their health status, being encouraged to complete their diary if they fall behind by positive messaging, and being thanked for their completion of a daily diary. Investigators should consider including these preferences when designing ePRO assessments. Incorporating patient preferences for ePRO design can ultimately help reduce patient burden and increase engagement, compliance, and improve data quality.

Identifiants

pubmed: 31313271
doi: 10.1007/s40271-019-00376-9
pii: 10.1007/s40271-019-00376-9
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

621-629

Références

Telemed J E Health. 2016 May;22(5):395-9
pubmed: 26451903
J Telemed Telecare. 2015 Jan;21(1):3-13
pubmed: 25147178
Qual Life Res. 2009 Feb;18(1):125-36
pubmed: 19152119
Patient. 2018 Dec;11(6):591-598
pubmed: 29968179
Patient. 2008 Apr 1;1(2):105-13
pubmed: 22272807
Rheumatology (Oxford). 2006 Jan;45(1):66-71
pubmed: 16263782
J Investig Allergol Clin Immunol. 2012;22(1):28-34
pubmed: 22448451
Int J Chron Obstruct Pulmon Dis. 2014 Sep 01;9:907-17
pubmed: 25214777
Value Health. 2009 Jun;12(4):419-29
pubmed: 19900250
Diabet Med. 2013 Aug;30(8):901-13
pubmed: 23324062
J Am Med Inform Assoc. 2012 Sep-Oct;19(5):696-704
pubmed: 22534082
Value Health. 2006 Mar-Apr;9(2):98-105
pubmed: 16626413
Comput Inform Nurs. 2011 Feb;29(2):75-80
pubmed: 21048498
J Headache Pain. 2012 Oct;13(7):537-41
pubmed: 22842873
Patient. 2015 Aug;8(4):301-9
pubmed: 25300613
Am J Respir Crit Care Med. 2011 Feb 1;183(3):323-9
pubmed: 20813886
Int J Chron Obstruct Pulmon Dis. 2015 Jan 07;10:79-94
pubmed: 25609942
Ther Innov Regul Sci. 2015 Nov;49(6):783-791
pubmed: 30222388
CA Cancer J Clin. 2012 Sep-Oct;62(5):337-47
pubmed: 22811342
Pain Res Manag. 2008 Sep-Oct;13(5):375-82
pubmed: 18958308
Pain. 2004 Feb;107(3):213-9
pubmed: 14736583
Am J Med. 1984 Aug;77(2):211-7
pubmed: 6380287
Conf Proc IEEE Eng Med Biol Soc. 2014;2014:3164-7
pubmed: 25570662
J Clin Epidemiol. 2007 Jan;60(1):8-17
pubmed: 17161749
COPD. 2009 Feb;6(1):59-63
pubmed: 19229709
BMJ. 2002 May 18;324(7347):1193-4
pubmed: 12016186
Support Care Cancer. 2013 Mar;21(3):889-99
pubmed: 23052911

Auteurs

Kelly M Dumais (KM)

ERT, 500 Rutherford Ave, Boston, MA, 02129, USA. kelly.dumais@ert.com.

Nadeeka Dias (N)

ERT, 500 Rutherford Ave, Boston, MA, 02129, USA.

Laura Khurana (L)

ERT, 500 Rutherford Ave, Boston, MA, 02129, USA.

Sarah Tressel Gary (ST)

ERT, 500 Rutherford Ave, Boston, MA, 02129, USA.

Brooke Witherspoon (B)

Endpoint Outcomes, Boston, MA, USA.

Christopher J Evans (CJ)

Endpoint Outcomes, Boston, MA, USA.

Susan M Dallabrida (SM)

ERT, 500 Rutherford Ave, Boston, MA, 02129, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH